Glycopyrrolate 01
Glycopyrrolate Injection
Product Images NDC 70069-011
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70069-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Glycopyrrolate 02
NDC 70069-011-01 is a single-dose vial of Glycopyrrolate Injection, USP for intramuscular or intravenous administration. This medication is manufactured for Somerset Therapeutics and contains benzyl alcohol. However, it is not for use in newborns. The usual dosage can be found in the package insert. The medication is made in India and the lot number is not readable due to the presence of a "No Varnish Area."*
Glycopyrrolate 03
Glycopyrrolate 04
NDC 70069-012-01 is a glycopyrrolate injection used for Intramuscular or Intravenous Administration. The container has a single dose of 2 mL with 0.4 mg strength. The medication is not suitable for newborns and contains Benzyl Alcohol. The usual dosage is mentioned in the package insert. The injection was manufactured for Somerset Therapeutics, LLC in Hollywood, FL 33024 but was made in India. A code TN/Drugs/T N00003457 along with a lot number and an expiration date 13160993 is also available. There is a non-Varnish area of dimensions 18.5x8 mm.*
Glycopyrrolate 05
Glycopyrrolate 06
This is a drug product with the generic name Glycopyrrolate, available in a 5 mL multiple dose vial for intramuscular or intravenous administration. The drug is labeled for use in adults and children but not in newborns, as it contains Benzyl Alcohol. The usual dosage for the drug is mentioned in the package insert. The drug should be stored in a controlled room temperature range of 20-25°C. The manufacturer of the product is Somerset Therapeutics, LLC based in Hollywood, FL, and made in India. The remaining text is not-available.*
Glycopyrrolate 07
Glycopyrrolate Injection, USP is a medication solution used to treat certain conditions related to excessive sweating and saliva production. The provided text is not a useful description and seems to contain some random characters and symbols.*
Glycopyrrolate 08
This is a description of a medication with NDC70069-014-01 as its identification code. The medication is "Water for Injection, USP" with 0.9% Benzyl Alcohol, NF as a preservative. It may also contain Glycopyrrolate, iononic acid, and Sodium hydroxide. The medication is administered through intravenous or intramuscular route. The medication must be stored at 20° to 25°C (68° to 77°F). The medication is available in a 20 mL multiple-dose vial with the code TN/Drugs/TNO0003457 13160095. The manufacturer is Somerset Therapetics, LLC, and it was made in India. This medication is for prescription-only use.*
Glycopyrrolate 09
The text is not available for generating a useful description as it consists of a mix of random characters and numerical values unrelated to any specific context or subject matter.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
